Final thoughts: GLP-1s need a strategy, not just coverage Covering Wegovy and other GLP-1s can be a high-impact move but only if its done right
Biocons Generics Business: Riding the GLP-1 Wave Biocons generics segment, which contributed 18% of the companys revenue , delivered an impressive 24% year-on-year growth , reaching 774 crore in Q2 FY26
In individuals with elevated baseline AST/ALT (non-alcoholic fatty liver, alcohol use, medication-related elevation), clinical studies have documented measurable enzyme normalization in the 4-8 week window
Contrave reviews In studies, over 56 weeks, the average weight loss in people taking Contrave was about 17 pounds
Non-GLP-1 orals (metformin, Contrave) are included in the mail pharmacy at no extra cost